Literature DB >> 34071041

Distribution of Flumequine in Intestinal Contents and Colon Tissue in Pigs after Its Therapeutic Use in the Drinking Water.

Jose M Rodríguez1, M Jose Diez1, Matilde Sierra1, Juan J Garcia1, Nelida Fernandez1, Raquel Diez1, Ana M Sahagun1.   

Abstract

Flumequine concentrations in plasma, colon tissue and intestinal contents were evaluated in 12 healthy pigs after oral administration (12 mg/kg every 24 h for 5 consecutive days in drinking water). Plasma, colon tissue and intestinal content samples were collected from animals sacrificed on days 3, 6 and 7. Concentrations were measured by high performance liquid chromatography after having validated the method, following the European Medicines Agency (EMA) requirements. The drug was not detected in any plasma sample. In colon tissue, concentrations were higher on day 3 (0.230 ± 0.033 µg/g, descending colon; 0.156 ± 0.093 µg/g, ascending colon) than on day 6 (0.187 ± 0.123 µg/g, descending colon; 0.107 ± 0.007 µg/g, ascending colon). Concentrations were considerably higher in intestinal contents, again on day 3 (1.349 ± 1.401 µg/g, descending colon; 0.591 ± 0.209 µg/g, ascending colon) than on days 6 (0.979 ± 0.346 µg/g, descending colon; 0.595 ± 0.075 µg/g, ascending colon) and 7 (0.247 ± 0.172 µg/g, descending colon; 0.172 ± 0.086 µg/g, ascending colon). Measured concentrations were lower than those effective against the most common intestinal pathogenic microorganisms in swine and, more specifically, Brachyspira hyodysenteriae.

Entities:  

Keywords:  HPLC; colon tissue; flumequine; intestinal content; oral administration, pig; plasma

Year:  2021        PMID: 34071041     DOI: 10.3390/ani11061514

Source DB:  PubMed          Journal:  Animals (Basel)        ISSN: 2076-2615            Impact factor:   2.752


  34 in total

Review 1.  Pharmacology of the fluoroquinolones: a perspective for the use in domestic animals.

Authors:  Marilyn Martinez; Patrick McDermott; Robert Walker
Journal:  Vet J       Date:  2005-09-09       Impact factor: 2.688

Review 2.  DNA topoisomerase II and its growing repertoire of biological functions.

Authors:  John L Nitiss
Journal:  Nat Rev Cancer       Date:  2009-04-20       Impact factor: 60.716

3.  Pharmacokinetics, metabolism and renal clearance of flumequine in veal calves.

Authors:  D J Mevius; H J Breukink; P J Guelen; T Jansen; B De Grève
Journal:  J Vet Pharmacol Ther       Date:  1990-06       Impact factor: 1.786

4.  New topoisomerase essential for chromosome segregation in E. coli.

Authors:  J Kato; Y Nishimura; R Imamura; H Niki; S Hiraga; H Suzuki
Journal:  Cell       Date:  1990-10-19       Impact factor: 41.582

5.  [Fish diseases].

Authors:  P J Werkman
Journal:  Tijdschr Diergeneeskd       Date:  1996-01-15

6.  Pharmacokinetics of flumequine in sheep after intravenous and intramuscular administration: bioavailability and tissue residue studies.

Authors:  J M Delmas; A M Chapel; V Gaudin; P Sanders
Journal:  J Vet Pharmacol Ther       Date:  1997-08       Impact factor: 1.786

7.  Pharmacokinetics and tissue disposition of danofloxacin in sheep.

Authors:  Q A McKellar; I F Gibson; R Z McCormack
Journal:  Biopharm Drug Dispos       Date:  1998-03       Impact factor: 1.627

Review 8.  Antimicrobial resistance in Brachyspira - An increasing problem for disease control.

Authors:  David J Hampson; Kittitat Lugsomya; Tom La; Nyree Dale Phillips; Darren J Trott; Sam Abraham
Journal:  Vet Microbiol       Date:  2018-12-17       Impact factor: 3.293

9.  Norfloxacin binds to human fecal material.

Authors:  C Edlund; L Lindqvist; C E Nord
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

10.  Evaluation of the in vitro activity of flumequine against field isolates of Brachyspira hyodysenteriae.

Authors:  Luis Miguel Aller-Morán; Francisco Javier Martínez-Lobo; Pedro Rubio; Ana Carvajal
Journal:  Res Vet Sci       Date:  2015-09-05       Impact factor: 2.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.